Literature DB >> 34764489

Deaths in children and young people in England after SARS-CoV-2 infection during the first pandemic year.

Clare Smith1,2, David Odd3,4, Rachel Harwood5,6, Joseph Ward7, Mike Linney8,9, Matthew Clark10, Dougal Hargreaves11, Shamez N Ladhani12,13, Elizabeth Draper14, Peter J Davis10,15, Simon E Kenny10,5,6, Elizabeth Whittaker16,17, Karen Luyt4, Russell Viner7, Lorna K Fraser18.   

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is rarely fatal in children and young people (CYP, <18 years old), but quantifying the risk of death is challenging because CYP are often infected with SARS-CoV-2 exhibiting no or minimal symptoms. To distinguish between CYP who died as a result of SARS-CoV-2 infection and those who died of another cause but were coincidentally infected with the virus, we undertook a clinical review of all CYP deaths with a positive SARS-CoV-2 test from March 2020 to February 2021. The predominant SARS-CoV-2 variants were wild-type and Alpha. Here we show that, of 12,023,568 CYP living in England, 3,105 died, including 61 who were positive for SARS-CoV-2. Of these deaths, 25 were due to SARS-CoV-2 infection (mortality rate, two per million), including 22 due to coronavirus disease 2019-the clinical disease associated with SARS-CoV-2 infection-and 3 were due to pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. In total, 99.995% of CYP with a positive SARS-CoV-2 test survived. CYP older than 10 years, Asian and Black ethnic backgrounds and comorbidities were over-represented in SARS-CoV-2-related deaths compared with other CYP deaths. These results are important for guiding decisions on shielding and vaccinating children. New variants might have different mortality risks and should be evaluated in a similar way.
© 2021. The Author(s), under exclusive licence to Springer Nature America, Inc.

Entities:  

Mesh:

Year:  2021        PMID: 34764489     DOI: 10.1038/s41591-021-01578-1

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  25 in total

1.  Association of Household Deprivation, Comorbidities, and COVID-19 Hospitalization in Children in Germany, January 2020 to July 2021.

Authors:  Nico Dragano; Olga Dortmann; Jörg Timm; Matthias Mohrmann; Rosemarie Wehner; Christoph J Rupprecht; Maria Scheider; Ertan Mayatepek; Morten Wahrendorf
Journal:  JAMA Netw Open       Date:  2022-10-03

2.  An assessment of the vaccination of school-aged children in England against SARS-CoV-2.

Authors:  Matt J Keeling; Sam E Moore
Journal:  BMC Med       Date:  2022-05-18       Impact factor: 11.150

Review 3.  Cardiac Complications of COVID-19 in Low-Risk Patients.

Authors:  Akash Srinivasan; Felyx Wong; Liam S Couch; Brian X Wang
Journal:  Viruses       Date:  2022-06-17       Impact factor: 5.818

4.  mRNA or ChAd0x1 COVID-19 Vaccination of Adolescents Induces Robust Antibody and Cellular Responses With Continued Recognition of Omicron Following mRNA-1273.

Authors:  Alexander C Dowell; Annabel A Powell; Chris Davis; Sam Scott; Nicola Logan; Brian J Willett; Rachel Bruton; Morenike Ayodele; Elizabeth Jinks; Juliet Gunn; Eliska Spalkova; Panagiota Sylla; Samantha M Nicol; Jianmin Zuo; Georgina Ireland; Ifeanyichukwu Okike; Frances Baawuah; Joanne Beckmann; Shazaad Ahmad; Joanna Garstang; Andrew J Brent; Bernadette Brent; Marie White; Aedin Collins; Francesca Davis; Ming Lim; Jonathan Cohen; Julia Kenny; Ezra Linley; John Poh; Gayatri Amirthalingam; Kevin Brown; Mary E Ramsay; Rafaq Azad; John Wright; Dagmar Waiblinger; Paul Moss; Shamez N Ladhani
Journal:  Front Immunol       Date:  2022-06-02       Impact factor: 8.786

5.  COVID-19 in Pediatrics: Demographic, Clinical, Laboratory, and Radiological Characteristics of Infected Patients With SARS-CoV-2.

Authors:  Maryam Najafinejad; Fatemeh Cheraghali; Bahman Aghcheli; Abdolhalim Rajabi; Leila Barati; Hamed Naziri; Mohammad Hadi Gharib; Alijan Tabarraei; Britt Nakstad; Alireza Tahamtan
Journal:  Front Pediatr       Date:  2022-01-13       Impact factor: 3.418

6.  Importance of Coronavirus Disease 2019 Vaccination in Children: Viewpoint and Recommendations of the Union of European National Societies of Pediatrics.

Authors:  Massimo Pettoello-Mantovani; Cristina Cardemil; Robert Cohen; Corinne Levy; Ida Giardino; Flavia Indrio; Eli Somekh
Journal:  J Pediatr       Date:  2021-12-30       Impact factor: 6.314

Review 7.  SARS-CoV-2 infections in children: Understanding diverse outcomes.

Authors:  Petter Brodin
Journal:  Immunity       Date:  2022-01-20       Impact factor: 31.745

8.  Clinical Picture and Risk Factors of Severe Respiratory Symptoms in COVID-19 in Children.

Authors:  Anna Mania; Kamil Faltin; Katarzyna Mazur-Melewska; Paweł Małecki; Katarzyna Jończyk-Potoczna; Karol Lubarski; Zuzanna Lewandowska; Agnieszka Cwalińska; Jowita Rosada-Kurasińska; Alicja Bartkowska-Śniatkowska; Magdalena Figlerowicz
Journal:  Viruses       Date:  2021-11-25       Impact factor: 5.048

9.  Which children and young people are at higher risk of severe disease and death after hospitalisation with SARS-CoV-2 infection in children and young people: A systematic review and individual patient meta-analysis.

Authors:  Rachel Harwood; Helen Yan; Nishanthi Talawila Da Camara; Clare Smith; Joseph Ward; Catrin Tudur-Smith; Michael Linney; Matthew Clark; Elizabeth Whittaker; Defne Saatci; Peter J Davis; Karen Luyt; Elizabeth S Draper; Simon E Kenny; Lorna K Fraser; Russell M Viner
Journal:  EClinicalMedicine       Date:  2022-02-11

10.  The COVID-19 pandemic in children and young people during 2020-2021: Learning about clinical presentation, patterns of spread, viral load, diagnosis and treatment.

Authors:  Igor Rudan; Davies Adeloye; Srinivasa Vittal Katikireddi; Josie Murray; Colin Simpson; Syed Ahmar Shah; Chris Robertson; Aziz Sheikh
Journal:  J Glob Health       Date:  2021-12-25       Impact factor: 7.664

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.